Improving pancreatic cancer screening using advanced ultrasound techniques
Official title: Multiparametric endoscopic ultrasound for improved pancreatic cancer screening and characterization
Funded at Sloan-Kettering Inst Can Research · NIH-11034663 · Data updated 2026-11-12
This study is testing a new way to use ultrasound to help find pancreatic cancer earlier and more accurately, especially for people who are at higher risk, so that they can get better treatment options.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | January 1, 2025 |
| Project end | December 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $263,086 |
| NIH project number | 1R21CA296688-01 |
| Project ID | NIH-11034663 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with specific genetic syndromes or familial predispositions that increase their risk of developing pancreatic cancer.
✕Less likely to help
Patients without a family history of pancreatic cancer or those not classified as high-risk individuals may not benefit from this research.
What this research studies
This research focuses on enhancing the screening and characterization of pancreatic cancer through a novel multiparametric endoscopic ultrasound (mpEUS) approach. It aims to develop a comprehensive imaging system that combines various ultrasound techniques to better evaluate pancreatic tissue, particularly for high-risk individuals. By utilizing advanced imaging modalities, the study seeks to identify early-stage pancreatic cancer and precursors that could lead to cancer, thereby improving early detection and treatment options for patients.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of pancreatic cancer, significantly improving patient outcomes and survival rates.
How similar studies have gone: Previous research has shown promise in using advanced imaging techniques for cancer detection, indicating that this approach could yield significant advancements in pancreatic cancer screening.
Where this research is happening
-
Sloan-Kettering Inst Can Research
New York, United States Active
Researchers
- Principal investigator: Burgess, Mark Thomas — Sloan-Kettering Inst Can Research
- Study coordinator: Burgess, Mark Thomas
Related research
Other NIH-funded projects on the same topics.
-
A targeted therapy plan using endoscopic heat treatment plus chemotherapy for pancreatic cancer
A patient-focused plan tests using a special endoscopic heat treatment together with chemotherapy to treat pancreatic cancer.
-
Advanced ultrasound to find early pancreatic cancer in people at high risk
This project combines several advanced ultrasound techniques to detect early pancreatic cancers and high-risk precancerous changes in people with strong family or genetic risk.
-
Combining Chemotherapy with Targeted Ablation for Pancreatic Cancer
This research is testing a new way to treat pancreatic cancer by combining standard chemotherapy with a targeted heat treatment called radiofrequency ablation.
-
Combining chemotherapy with a new treatment method for pancreatic cancer
This study is looking at how well combining regular chemotherapy with a special treatment called endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) works for people with pancreatic cancer, hoping to boost their immune response and improve their chances of recovery.
-
Microbial Dysbiosis and Its Role in Pancreatic Cancer
A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.
-
Modulating deep brain activity with focused ultrasound for cocaine use disorder
A study will test whether targeting a deep brain region with focused ultrasound can alter brain signals related to craving in people with cocaine use disorder.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.